Growth Metrics

Pfizer (PFE) Preferred Shares (2016 - 2020)

Pfizer has reported Preferred Shares over the past 12 years, most recently at $17.0 million for Q1 2020.

  • Quarterly Preferred Shares fell 10.53% to $17.0 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $17.0 million through Mar 2020, down 10.53% year-over-year, with the annual reading at $17.0 million for FY2019, 10.53% down from the prior year.
  • Preferred Shares was $17.0 million for Q1 2020 at Pfizer, roughly flat from $17.0 million in the prior quarter.
  • Over five years, Preferred Shares peaked at $26.0 million in Q2 2016 and troughed at $17.0 million in Q4 2019.
  • The 5-year median for Preferred Shares is $21.0 million (2017), against an average of $21.1 million.
  • Year-over-year, Preferred Shares fell 7.14% in 2016 and then fell 13.04% in 2018.
  • A 5-year view of Preferred Shares shows it stood at $24.0 million in 2016, then fell by 12.5% to $21.0 million in 2017, then decreased by 9.52% to $19.0 million in 2018, then decreased by 10.53% to $17.0 million in 2019, then changed by 0.0% to $17.0 million in 2020.
  • Per Business Quant, the three most recent readings for PFE's Preferred Shares are $17.0 million (Q1 2020), $17.0 million (Q4 2019), and $18.0 million (Q3 2019).